Published on
November 2, 2021
- 17:14 GMT
Clinical trial of an original Russian drug for the treatment of lung cancer starts in China
SAINT PETERBURG, RUSSIA, November 2, 2021 /EINPresswire.com/ -- A Joint Venture Company of BIOCAD and Shanghai Pharmaceuticals Holding announced the enrollment of the first Chinese patient in Phase III international multicenter clinical trial of …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
